Agios Pharma (DE:8AP)
FRANKFURT:8AP
Holding DE:8AP?
Track your performance easily

Agios Pharma (8AP) Technical Analysis

0 Followers

Summary of all the Indicators

Overall Consensus
Buy
15Bullish
1Neutral
6Bearish
Technical Analysis Consensus
Sell
3Bullish
1Neutral
6Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Agios Pharma’s (8AP) Moving Averages Convergence Divergence (MACD) indicator is 3.50, suggesting Agios Pharma is a Sell.
Agios Pharma’s (8AP) 20-Day exponential moving average is 45.70, while Agios Pharma’s (8AP) share price is €55, making it a Buy.
Agios Pharma’s (8AP) 50-Day exponential moving average is 42.62, while Agios Pharma’s (8AP) share price is €55, making it a Buy.

Agios Pharma (8AP) Pivot Points

Nov 14, 2024, 06:13 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
56.00
56.00
56.00
56.00
56.00
56.00
56.00
Fibonacci
56.00
56.00
56.00
56.00
56.00
56.00
56.00
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Agios Pharma (8AP) Moving Averages

Nov 14, 2024, 06:13 AM
Period
Simple
Exponential
MA5
52.72Buy
52.48Buy
MA10
47.06Buy
49.07Buy
MA20
44.22Buy
45.70Buy
MA50
41.38Buy
42.62Buy
MA100
41.15Buy
40.40Buy
MA200
35.87Buy
35.03Buy
Agios Pharma’s (8AP) 10-Day exponential moving average is 49.07, while Agios Pharma’s (8AP) share price is €55, making it a Buy.
Agios Pharma’s (8AP) 100-Day exponential moving average is 40.40, while Agios Pharma’s (8AP) share price is €55, making it a Buy.
Agios Pharma’s (8AP) stock price is €55 and Agios Pharma’s (8AP) 50-day simple moving average is 41.38, creating a Buy signal.
Agios Pharma’s (8AP) stock price is €55 and Agios Pharma’s (8AP) 100-day simple moving average is 41.15, creating a Buy signal.
Agios Pharma’s (8AP) stock price is €55 and Agios Pharma’s (8AP) 200-day simple moving average is 35.87, creating a Buy signal.

Agios Pharma (8AP) Technical Indicators

Nov 14, 2024, 06:13 AM
Name
Value
Implied Action
RSI (14)
77.70
Sell
STOCH (9,6)
97.89
Sell
STOCHRSI (14)
97.89
Sell
MACD (12,26)
3.50
Sell
ADX (14)
26.42
Neutral
Williams %R
-6.33
Sell
CCI (14)
169.14
Sell
ATR (14)
1.46
-
Ultimate Oscillator
86.37
Buy
ROC
34.80
Buy
Agios Pharma’s (8AP) Relative Strength Index (RSI) is 77.70, creating a Sell signal.
Agios Pharma’s (8AP) Trend Strength Indicator (ADX) is 26.42, creating a Neutral signal.
Agios Pharma’s (8AP) Commodity Channel Index (CCI) is 169.14, creating a Sell signal.
Agios Pharma’s (8AP) Price Rate of Change (ROC) is 34.80, creating a Buy signal.

FAQ

Is 8AP a Buy, Hold, or Sell?
Based on 8AP’s technical indicators, 8AP is a Buy.
    What is 8AP’s RSI (14)?
    8AP’s RSI (14) is 77.70, which suggests 8AP is a Sell.
      What is 8AP’s MACD?
      8AP’s MACD is 3.50, which suggests 8AP is a Sell.
        What is 8AP’s 5-day moving average?
        8AP’s 5-day moving average is 52.72, which suggests 8AP is a Buy.
          What is 8AP’s 20-day moving average?
          8AP 20-day moving average is 44.22, which suggests 8AP is a Buy.
            What is 8AP’s 50-day moving average?
            8AP’s 50-day moving average is 41.38, which suggests 8AP is a Buy.
              What is 8AP’s 200-day moving average?
              8AP’s 200-day moving average is 35.87, which suggests 8AP is a Buy.
                What is 8AP’s Williams % R (14)?
                8AP’s Williams % R (14) is -6.33, which suggests 8AP is a Sell.
                  What is 8AP’s CCI (14)?
                  8AP’s CCI (14) is 169.14, which suggests 8AP is a Sell.
                    What is the share price of Agios Pharma?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis